Improving Global Health

VTC Researcher in Bangladesh holding baby with motherFaculty researchers at the Vaccine Testing Center (VTC) study human vaccines with the goal of understanding and preventing infectious diseases around the globe. The VTC is in the Department of Microbiology and Molecular Genetics, which bridges both the University of Vermont College of Agriculture and Life Sciences and the Larner College of Medicine.

Our team is particularly interested in new vaccines with the potential to prevent or control infectious diseases in developing countries. We are a diverse team of clinicians, study coordinators, scientists, and laboratory personnel. Volunteers are critical to our work and our human research studies are designed and performed with rigorous oversight and safety.

Research 

Lab Tech looking in microscope

The Vaccine Testing Center's team of scientists and researchers are committed to solving the world’s most pressing infectious disease challenges. Our research spans the translational spectrum from lab-based human immunology to domestic clinical trials to large-scale international field research. Together with national and international collaborators and local volunteers, we help develop vaccines to address global infectious diseases, including rotavirus, cholera, dengue and other flaviviruses. More VTC research.

Volunteer

JointheFightButton180by120

Want to help your global community? 

The VTC will screen healthy adults aged 18–50 for future vaccine research of mosquito-borne viruses. More information on this will be available soon.

Interested in volunteering for a COVID-19 Vaccine Trial?

Visit the NIH's online CoPVN Volunteer Screening Registry. Learn more about the COVID-19 Prevention Network Volunteer Information  and the studies that will be conducted.

TGIR COBRE

 

Data Visualization

The Translational Global Infectious Disease Research Center (TGIR) Center of Biomedical Research Excellence (COBRE) is funded by the National Institutes of Health (NIH). This innovative center will leverage UVM's substantial existing strengths in global infectious diseases research, complex systems and computational modeling to develop creative, translational approaches to prevent and control infectious disease around the world.

To learn more visit the TGIR website.

Donations to the Vaccine Testing Center support groundbreaking research and clinical trials that improve people's quality of life and overall global health. More

Donate Button

Director speaks about COVID vaccines in the U.S.

Smiling Dr. Kirkpatrick leaning against hood in the lab

WCAX recently spoke with Dr. Beth Kirkpatrick to learn more about the development and goals of a COVID vaccine in the U.S. See the interview on WCAX. Dr. Kirkpatrick, and infectious disease specialist, is the founder and Director of the Vaccine Testing Center at UVM. 

Novel Coronavirus

Efficacy Trials of several COVID-19 vaccines underway in the U.S.

The National Institutes of Health has opened a national registry called the CoPVN Volunteer Screening Registry for those interested in participating in one of the Phase III efficacy trials. Learn more about the COVID-19 Prevention Network Volunteer Information  and the studies that will be conducted.

VTC Researcher on COVID Vaccines

Kristen Pierce, MD, smiling headshot

Dr. Kristen Pierce of the Vaccine Testing Center was recently interviewed on our local WPTZ 5 station. Hear what our expert has to say about the COVID vaccines currently in national Phase lll trials.

Diehl Establishes COVID-19 Antibody Testing Capabilities

Sean Diehl, PhD in lab coat smilingVTC researcher Dr. Sean Diehl was recently interviewed on WCAX about his lab's development of an accurate, inexpensive, open-source serology test that can be used for large-scale tracking of the Coronavirus. The team is hopeful that the test can eventually be put to good use to help Vermont and other states research and monitor the spread of COVID-19 among their populations.